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The number of studies evaluating the effect of
environmental exposure to genotoxic agents in
children has rapidly grown in the last years
(Neri et al. 2005b; Suk et al. 2003), boosted
by two main considerations: a) Children may
be more sensitive than adults to genotoxic
agents, and b) genetic damage occurring at
young ages may affect the lifetime risk of
delayed adverse health outcomes (Landrigan
et al. 2003; Wild and Kleinjans 2003).
Among the several adverse health effects
that have been studied in children exposed to
environmental hazards, genetic damage has
received a particular interest, especially after
the recent publication of epidemiologic stud-
ies showing that a high frequency of chromo-
some damage predicts cancer in healthy adults
(Bonassi et al. 2004).
The use of genetic biomarkers in children
raises a number of issues (Neri et al. 2005a).
On the other hand, studies in children are
essential to make use of the ﬁndings in public
and environmental health. Ethical issues are
related to protection of privacy, causing no
harm, and leaving the child with a “feel-good
experience.” Legal issues of data protection,
conﬁdentiality, and autonomy of the child are
also important. Further, a direct application
to pediatric populations of biomarkers of
genetic damage that have been proven useful
in adults may be misleading. Differences in
exposure to and intake of environmental
agents, xenobiotic metabolism, and the role
of infectious diseases may alter the reliability
of some biomarkers when translated from
adults to children. Finally, to allow a correct
interpretation of ﬁndings from these studies,
a basic question must be addressed: What is
the estimate of the spontaneous occurrence of
genetic damage in children?
The micronucleus (MN) test in periph-
eral blood lymphocytes with the cytokinesis
block method is one of the most popular
assays of genetic damage in human biomoni-
toring (Bonassi et al. 2005). Details about the
assay can be found in the articles published
by the Human Micronucleus International
Collaborative Study (HUMN) (Fenech et al.
1999, 2003). The growing interest in this
test, mostly due to the easy use of MN in
monitoring exposure to genotoxic agents, is
fueled also by the accumulating evidence that
the frequency of MN in healthy subjects may
be considered a marker of risk for cancer
(Tucker and Preston 1996) and cardiovascu-
lar disease (Andreassi and Botto 2003). The
performance of this biomarker in ﬁeld studies
involving children exposed to environmental
agents has been recently reviewed (Neri et al.
2003, 2005b).
Despite the large number of advantages
that justify the popularity of this assay, there
is an evident limitation—the large inter- and
intralaboratory variability in the MN fre-
quency. This variability may be explained
partially by technical reasons, genetic variabil-
ity, or sampling error. However, interscorer
discrepancy and protocol differences (when
different laboratories are involved) have been
shown to be the most important sources of
variability (Bonassi et al. 2001).
The meta- and pooled analyses represent
the ideal statistical tools for computing sum-
mary estimates of a biomarker frequency
using data from different studies (Greenland
1987). The advantages and the limitations of
meta- and pooled analysis have been dis-
cussed in many articles, and in many aspects
these methods are complementary (Taioli and
Bonassi 2002).
In this study, we identiﬁed the published
studies reporting MN during childhood (age
range, 0–18 years) with the aim of performing
a meta-analysis of MN frequency for referent
children and providing a meta-estimate of
the MN baseline value. Moreover, a pooled
analysis of individual data available from pub-
lished studies and from the HUMN database
(Bonassi et al. 2001) was performed with the
same purpose.
Materials and Methods
Search strategy and studies selection. Individuals
from birth to late adolescence (age range,
0–18 years) were considered as children. The
studies selected for inclusion in the meta-
analysis were identified by systematically
searching the MedLine/PubMed database
(National Library of Medicine, National
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The number of studies evaluating the effect of environmental exposure to genotoxic agents in
children has rapidly increased in the last few years. The frequency of micronuclei (MN) in periph-
eral blood lymphocytes determined with the cytokinesis block assay is among the most popular
biomarkers used for this purpose, although large inter- and intralaboratory variability of this end
point has been observed in population studies. The availability of reference measures is therefore
necessary for laboratories to validate protocols and analytical procedures, and for molecular epi-
demiologists, as well, to estimate the statistical power of studies and to assess the quality of data.
In this article, we provide estimates of the baseline frequency of MN in children, conducting a
meta-analysis of MN frequency reported by ﬁeld studies in children and a pooled analysis of indi-
vidual data [available from published studies and from the Human Micronucleus International
Collaborative Study (HUMN) database]. Thirteen articles were selected for meta-analysis, and
individual data included in the pooled analysis were retrieved from the databases of 12 labora-
tories. Overall means of 4.48 [95% confidence interval (CI), 3.35–5.98] and 5.70 (95% CI,
4.29–7.56) MN per 1,000 binucleated cells were estimated by the meta- and pooled analysis,
respectively. A clear effect of age was detected, even within the restricted range of pediatric age
considered, with signiﬁcantly lower frequency values in newborns. No inﬂuence of sex was found.
The study showed the advantage of using data from large collaborative studies and suggested
a synergistic use of meta- and pooled analysis. Key words: biomarker, children, environmental
exposure, genetic damage, meta-analysis, micronucleus assay, molecular epidemiology, pooled
analysis. Environ Health Perspect 113:1226–1229 (2005). doi:10.1289/ehp.7806 available via
http://dx.doi.org/ [Online 31 May 2005]Institutes of Health, Bethesda, MD, USA;
http://www.ncbi.nlm.nih.gov/PubMed). The
terms “micronucleus tests” existing since 1989
and “micronuclei” existing since 1990 were
used as medical subject heading (MeSH) key
word. To cover previous years, a free text search
with terms “micronucleus” and “micronuclei”
was performed. The categories “All Child:
0–18 years,” “Human,” “Language: English,”
and “Publication Date: from January 1st, 1985
to September 1st, 2004” were set as search
limits. This allowed retrieving 168 citations.
Only studies measuring MN frequency
in lymphocytes with the cytokinesis block
method (Fenech and Morley 1985) and with
at least 10 subjects in the referent group were
included. Referent children exposed to geno-
toxic agents or affected by any disease were
also excluded from the statistical analyses.
MN frequency was always reported as the
number of MN per 1,000 (‰) binucleated
cells. According to these criteria, 13 studies
(Table 1), accounting for 440 subjects, were
found to be suitable for the meta-analysis
(Barale et al. 1998; Bilban and Vaupotic 2001;
Da Cruz et al. 1994; Dulout et al. 1996;
Fellay-Reynier et al. 2000; Fenech et al. 1997;
Livingston et al. 1997; Maluf and Erdtmann
2001; Migliore et al. 1991; Mikhalevich et al.
2000; Shi et al. 2000; Vleminckx et al. 1997;
Zotti-Martelli et al. 1999). One study with a
small number of 19-year-old subjects was also
included (Barale et al. 1998). Three different
referent groups identified in a single study
(Vleminckx et al. 1997) were treated as inde-
pendent in the analysis.
Six of the 13 studies included in the meta-
analysis reported individual data for 103 chil-
dren (da Cruz et al. 1994; Dulout et al. 1996;
Fellay-Reynier et al. 2000; Maluf and Erdtmann
2001; Migliore et al. 1991; Mikhalevich et al.
2000) and were used also in the pooled analysis,
together with 229 subjects from the HUMN
database (Bonassi et al. 2001).
Statistical methods. Meta-analysis. We
computed a summary estimate of the MN fre-
quency applying the random-effects linear
model to the natural logarithm of the MN
mean of each study (DerSimonian and Laird
1986). This model takes into account two
sources of variability: the error in estimating
the ith MN mean in repeated samples from
the same population the ith study belongs
to, and the heterogeneity between studies.
Although the former variability is assumed to
be known and estimated by the standard error
reported for each study, the latter (heterogene-
ity) was estimated from the model and found
to be highly signiﬁcant [Q = 308.14 (14 df),
p < 0.001]. The analysis was carried out with
STATA statistical software (STATA statistical
software, release 7.0; Stata Corp., College
Station, TX, USA); the random-effects model
was performed with the procedure META,
and the diagnostics, such as funnel plot, with
the procedures METAINF and METABIAS.
Pooled analysis. We obtained sex-speciﬁc
and age-group–speciﬁc MN mean frequencies
by ﬁtting a negative binomial random-effects
model to the MN count of each subject
(Lindsey 1995). The negative binomial model
was used to account for data overdispersion,
whereas the clustered nature of data (i.e., the
fact that the correlation between data within
laboratories is likely to be larger than that
between laboratories) was taken into considera-
tion by introducing in the model a random
effect due to the laboratory. The analysis was
performed with MLwiN statistical software
(version 1.10; Centre for Multilevel Modelling,
Institute of Education, University of London,
London, UK).
Results
Meta-analysis. The MN frequency for each
study included in the meta-analysis is reported
in Table 1 along with the size of the study and
the age range investigated. The overall meta-
estimate of the MN frequency was 4.48 ‰
[95% confidence interval (CI), 3.35–5.98].
To evaluate the impact of single studies on
this summary estimate of MN frequency, we
performed a sensitivity analysis estimating the
overall MN frequency after cyclically remov-
ing single studies. This approach showed the
absence of inﬂuential studies, with meta-esti-
mates of the MN frequency ranging from 4.77
to 4.22 ‰.
Pooled analysis. The layout of data selected
for the pooled analysis is reported in Table 2.
This analysis is more powerful with respect to
meta-analysis because potential confounding
factors, such as age and sex, are accounted for.
Age-group–specific and sex-specific pooled
estimates computed from the random-effects
model are shown in Table 3. Poor information
was available about ethnic characteristics,
although the large majority of children in the
study came from European countries. The
pooled mean estimate of the MN frequency
was 5.70 ‰ (95% CI, 4.29–7.56) when all
332 referent subjects were considered. While
pooled-mean values were similar for males
(5.94 ‰; 95% CI, 4.39–8.04) and females
(5.54 ‰; 95% CI, 4.13–7.4), MN frequency
was clearly associated with age. Frequency val-
ues were very low in children < 1 year of age
(3.27 ‰; 95% CI, 2.22–4.82) and increased
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Table 1. Field studies of MN in children included in the meta-analysis.
No. of referent children MN Age range
Reference (total no. of subjects in study) (mean ± SD) (years)
Shi et al. 2000 20 (68) 1.70 ± 1.83 0–10
Barale et al. 1998 136 (1,650) 2.20 ± 2.22 0–19
Zotti-Martelli et al. 1999 30 (72) 2.26 ± 2.35 15 ± 2.0a
Fellay-Reynier et al. 2000 20 (41) 2.71 ± 2.60 0–18
Vleminckx et al. 1997b 33 (220) 2.94 ± 2.46 6–15
31 (220) 4.19 ± 3.50 6–14
25 (220) 4.76 ± 5.00 6–15
Migliore et al. 1991 15 (45) 4.14 ± 1.75 1–12
Maluf and Erdtmann 2001 30 (74) 4.65 ± 2.25 0–17
Livingston et al. 1997 31 (80) 5.16 ± 2.51 4–14
Dulout et al. 1996 12 (44) 5.58 ± 5.51 8–14
Da Cruz et al. 1994 16 (276) 7.33 ± 3.88 1–18
Bilban and Vaupotic 2001 20 (105) 9.00 ± 3.80 8–12
Fenech et al. 1997 11 (116) 9.80 ± 3.32 12–15
Mikhalevich et al. 2000 10 (30) 9.92 ± 2.70 14–17
Meta-estimate 440 (3,261) 4.48 ± 0.66c 0–19
aMean ± SD. bThree independently selected groups of referent children were included in the study (see “Materials and
Methods” for details). cSE approximate.
Table 2. Field studies of MN in children included in the pooled analysis and crude pooled estimates.
No. of MN Age range Males
Author referents (mean ± SD) Range (years) (%)
Barale (HUMN) 119 2.43 ± 2.39 0.00–10.07 9–18 56
Fellay-Reynier et al. 2000 20 2.71 ± 2.60 0.00–6.78 0–18 30
Migliore et al. 1991 15 4.14 ± 1.75 1.88–7.53 1–12 40
Maluf and Erdtmann 2001 30 4.65 ± 2.24 1.50–12.00 0–17 60
Dulout et al. 1996 12 5.58 ± 5.47 0.00–19.00 8–14 25
Garcia (HUMN) 19 5.63 ± 3.32 0.00–10.00 7–15 32
Da Cruz et al. 1994 16 7.33 ± 3.88 1.00–18.00 1–18 44
Vorobtsova (HUMN) 8 7.38 ± 3.07 2.00–12.00 9–17 38
Chang et al. (HUMN) 54 8.54 ± 7.71 1.12–49.30 0–17 57
Scarfì et al. (HUMN) 22 9.44 ± 3.89 3.68–19.19 0–18 45
Mikhalevich et al. 2000 10 9.92 ± 2.70 5.77–14.00 14–17 40
Muller et al. (HUMN) 7 10.29 ± 9.76 3.00–31.00 7–14 14
Crude pooled estimate 332 5.23 ± 5.07 0.00–49.30 0–18 49
HUMN, data from the HUMN database (Bonassi et al. 2001).
Baseline micronuclei frequency in childrensignificantly thereafter, reaching the level of
7.05 ‰ (95% CI, 5.01–9.94) in the 15- to
19-year-old age group (chi-square test for
trend, p < 0.001).
Discussion
The main purpose of this study was to provide
reference values for researchers planning stud-
ies on genomic damage in children. We used
two complementary approaches to compute
summary measures of baseline MN frequency
in children. Meta-analysis provided summary
measures that, although affected by a certain
degree of heterogeneity, are considered to be
representative of studies published in the liter-
ature. Pooled analysis, although limited to
six published studies (those for which individ-
ual data were available), included 229 subjects
(from six laboratories) from the HUMN data-
base (Bonassi et al. 2001) and allowed the
computation of pooled estimates adjusted for
age and sex.
The estimates of the baseline MN fre-
quency in children obtained by the two
approaches were by large consistent, especially
considering CIs. The lower mean value esti-
mated by meta-analysis (4.48 vs. 5.70 ‰,
adjusted for age and sex), considering that
mean ages in the laboratories contributing
data to meta-analysis and in those considered
for the pooled analysis were similar, is likely to
be attributable to a different distribution of
absolute values of MN frequency in the two
sets of data. This is not surprising because
studies based on cytogenetic biomarkers suffer
from a certain degree of heterogeneity among
laboratories, and absolute values may differ
even largely.
The availability of reference values is
important for research teams and laboratories
that need to validate protocols and analytical
procedures as well as to estimate the statistical
power of ﬁeld studies and check the quality of
data. For this purpose, baseline MN frequen-
cies for the cytokinesis block assay have been
published for an adult population (Bonassi
et al. 2001).
Age is the most important predictor of
MN frequency, as described by cooperative
studies and reported in the literature (Bolognesi
et al. 1997; Bonassi et al. 2001). However,
despite the high number of subjects evaluated,
only differences between the extent of genetic
stability in adults and in children were
described. Recently, data from a review of stud-
ies conducted in children exposed to a variety of
mutagens, although limited, pointed to an
inﬂuence of age even in the ﬁrst two decades of
life (Neri et al. 2003).
In the present study, the effect of age was
evident even within the restricted age range
considered in pooled analysis (0–19 years).
The low frequency of MN detected in chil-
dren < 1 year of age is noteworthy, given the
growing number of studies performed on the
cord blood, an easily accessible source of
DNA. MN numbers were very low at birth
(3.27 ‰) and increased by 66% in children
1–4 years of age (5.43 ‰), an increase that
accounted for most of the age effect on MN
frequency described in the literature. Besides
the major challenges posed by the leaving of
the protected intrauterine environment, other
changes occurring in the first years of age,
such as solid diet, vaccinations, and viral dis-
eases, provide plausible explanations for this
dramatic increase.
No difference in MN frequency was found
by sex in our pooled analysis. The effect of sex
has been repeatedly reported in adult popu-
lations, and a recently published pooled analy-
sis estimated a 19% higher MN frequency in
females than in males (Bonassi et al. 1995,
2001). However, the influence of sex was
limited (and not statistically significant) in
subjects ≤ 40 years of age and became more
pronounced in older subjects (Bonassi et al.
2001). Possible biologic explanation include a
sex-related aneuploidy phenomenon and the
implication of sexual hormones (Bonassi et al.
1995). Findings reported by Neri et al. (2003)
failed to show any clear effect of sex on MN
frequency in children.
In conclusion, these results address an
increasing request from researchers performing
epidemiologic studies in children based on
biomarkers—specifically, the availability of
specific reference values in pediatric popula-
tions. The MN baseline values provided here
are meant for the planning phase of a study
and should not justify the conduct of future
studies among children that exclude the identi-
ﬁcation of properly selected referent (control)
subjects. Besides the main study ﬁndings, we
showed here the advantage of using data from
large collaborative research projects to improve
the design of future ﬁeld studies, including the
efﬁciency of the statistical analysis.
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